Literature DB >> 30505531

Surgical management of non-cystic fibrosis bronchiectasis.

Miyako Hiramatsu1, Yuji Shiraishi1.   

Abstract

Non-cystic fibrosis bronchiectasis (bronchiectasis) is an abnormal dilatation of the bronchi and bronchioles, resulting from a prolonged recurrent infectious process due to various causes and predisposing factors. This disease has several etiologies and affects a heterogeneous population of patients. The most important viewpoint for the surgical management of bronchiectasis is to select appropriate candidates for surgery and conduct suitable anatomic lung resections at the right time under appropriate conditions. The ideal candidates for lung resection are symptomatic patients with focal disease due to truly localized bronchial pathology regardless of optimal and absolute medical management.

Entities:  

Keywords:  Bronchiectasis; lung; surgery

Year:  2018        PMID: 30505531      PMCID: PMC6218362          DOI: 10.21037/jtd.2018.08.128

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  67 in total

1.  Surgical management of childhood bronchiectasis due to infectious disease.

Authors:  Gokhan Haciibrahimoglu; Mithat Fazlioglu; Aysun Olcmen; Atilla Gurses; Mehmet Ali Bedirhan
Journal:  J Thorac Cardiovasc Surg       Date:  2004-05       Impact factor: 5.209

2.  Current surgical therapy for bronchiectasis: surgical results and predictive factors in 86 patients.

Authors:  Akın Eraslan Balci; Tansel Ansal Balci; Mehmet Oğuzhan Ozyurtan
Journal:  Ann Thorac Surg       Date:  2013-11-05       Impact factor: 4.330

3.  Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.

Authors:  Kyeongman Jeon; O Jung Kwon; Nam Yong Lee; Bum-Joon Kim; Yoon-Hoh Kook; Seung-Heon Lee; Young Kil Park; Chang Ki Kim; Won-Jung Koh
Journal:  Am J Respir Crit Care Med       Date:  2009-08-06       Impact factor: 21.405

Review 4.  Pseudomonas aeruginosa: new insights into pathogenesis and host defenses.

Authors:  Shaan L Gellatly; Robert E W Hancock
Journal:  Pathog Dis       Date:  2013-03-15       Impact factor: 3.166

5.  Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.

Authors:  Won-Jung Koh; Kyeongman Jeon; Nam Yong Lee; Bum-Joon Kim; Yoon-Hoh Kook; Seung-Heon Lee; Young Kil Park; Chang Ki Kim; Sung Jae Shin; Gwen A Huitt; Charles L Daley; O Jung Kwon
Journal:  Am J Respir Crit Care Med       Date:  2010-09-10       Impact factor: 21.405

6.  Use of three-dimensional computed tomographic angiography of pulmonary vessels for lung resections.

Authors:  Shun-ichi Watanabe; Kazunori Arai; Toshio Watanabe; Wataru Koda; Hiroshi Urayama
Journal:  Ann Thorac Surg       Date:  2003-02       Impact factor: 4.330

7.  Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.

Authors:  Thierry Bienvenu; Isabelle Sermet-Gaudelus; Pierre-Regis Burgel; Dominique Hubert; Bruno Crestani; Laurence Bassinet; Daniel Dusser; Isabelle Fajac
Journal:  Am J Respir Crit Care Med       Date:  2010-02-18       Impact factor: 21.405

8.  Anatomic lung resection for nontuberculous mycobacterial disease.

Authors:  John D Mitchell; Amy Bishop; Amanda Cafaro; Michael J Weyant; Marvin Pomerantz
Journal:  Ann Thorac Surg       Date:  2008-06       Impact factor: 4.330

9.  A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan.

Authors:  Kozo Morimoto; Kazuro Iwai; Kazuhiro Uchimura; Masao Okumura; Takashi Yoshiyama; Kozo Yoshimori; Hideo Ogata; Atsuyuki Kurashima; Akihiko Gemma; Shoji Kudoh
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 10.  Update on the epidemiology of pulmonary nontuberculous mycobacterial infections.

Authors:  Brian A Kendall; Kevin L Winthrop
Journal:  Semin Respir Crit Care Med       Date:  2013-03-04       Impact factor: 3.119

View more
  4 in total

1.  Physical Function and Health-Related Quality of Life after Surgery for Nontuberculous Mycobacterial Pulmonary Disease: A Prospective Cohort Study.

Authors:  Yuki Kuroyama; Mitsuru Tabusadani; Shunya Omatsu; Miyako Hiramatsu; Yuji Shiraishi; Hiroshi Kimura; Hideaki Senjyu
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-08-26       Impact factor: 1.889

Review 2.  Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis.

Authors:  Sherstin T Lommatzsch
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

3.  Surgical treatment of non-cystic fibrosis bronchiectasis in Central Europe.

Authors:  Alaa Selman; Hayan Merhej; Tomoyuki Nakagiri; Norman Zinne; Tobias Goecke; Axel Haverich; Patrick Zardo
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 2.895

Review 4.  Bronchiectasis in Primary Antibody Deficiencies: A Multidisciplinary Approach.

Authors:  Luke A Wall; Elizabeth L Wisner; Kevin S Gipson; Ricardo U Sorensen
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.